RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. The company is developing Ataciguat: a small molecule drug developed to slow the progression of  Calcific Aortic Valve Stenosis (CAVS) to delay surgical valve replacement in patients.